Related references
Note: Only part of the references are listed.The discovery and development of belimumab: the anti-BLyS-lupus connection
William Stohl et al.
NATURE BIOTECHNOLOGY (2012)
Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial
Ellen M. Ginzler et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Intrarenal production of B-cell survival factors in human lupus nephritis
Matthias A. Neusser et al.
MODERN PATHOLOGY (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
Belimumab: A BLyS-Specific Inhibitor for Systemic Lupus Erythematosus
Amy K. Wiglesworth et al.
ANNALS OF PHARMACOTHERAPY (2010)
Selective Blockade of BAFF for the Prevention and Treatment of Systemic Lupus Erythematosus Nephritis in NZM2410 Mice
Meera Ramanujam et al.
ARTHRITIS AND RHEUMATISM (2010)
Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial
Joan T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
Raised serum level of APRIL in patients with systemic lupus erythematosus: Correlations with disease activity indices
M. Hegazy et al.
CLINICAL IMMUNOLOGY (2010)
B Cell-Targeted Therapies for Systemic Lupus Erythematosus An Update on Clinical Trial Data
R. John Looney
DRUGS (2010)
B cells as therapeutic targets in SLE
Inaki Sanz et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus
J. Morel et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Systemic Activation of the Immune System Induces Aberrant GAFF and APRIL Expression in B Cells in Patients With Systemic Lupus Erythematosus
Van Trung Chu et al.
ARTHRITIS AND RHEUMATISM (2009)
The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus
Michael P. Cancro et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2008)
Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms
Annie George-Chandy et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Expression of BAFF and BAFF-R in the synovial tissue of patients with rheumatoid arthritis
K. Nakajima et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2007)
B cells move to centre stage: novel opportunities for autoimmune disease treatment
Jeffrey L. Browning
NATURE REVIEWS DRUG DISCOVERY (2006)
Similarities and differences between selective and nonselective BAFF blockade in murine SLE
M Ramanujam et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
An APRIL to remember: novel TNF ligands as therapeutic targets
SR Dillon et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels
CE Collins et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Messenger RNA for FOXP3 in the urine of renal-allograft recipients
T Muthukumar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
BLyS and APRIL in rheumatoid arthritis
TM Seyler et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Increased levels of APRIL (a proliferation-inducing ligand) mRNA in multiple sclerosis
M Thangarajh et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Raised serum APRIL levels in patients with systemic lupus erythematosus
T Koyama et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
The classification of glomerulonephritis in systemic lupus erythematosus revisited
JJ Weening et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
B cell depletion as a novel treatment for systemic lupus erythematosus - A phase I/II dose-escalation trial of rituximab
RJ Looney et al.
ARTHRITIS AND RHEUMATISM (2004)
B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus - Longitudinal observations
W Stohl et al.
ARTHRITIS AND RHEUMATISM (2003)
Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine
BG Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
JA Gross et al.
NATURE (2000)
Share Paper
